SL
EXAS

Salomon & Ludwin’s Exact Sciences EXAS Stock Holding History

Salomon & Ludwin’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9
Closed -$914 – 2132
2025
Q4 		$914 Hold
9
– – ﹤0.01% 2067
2025
Q3 		$510 Buy
+9
New +$450 ﹤0.01% 2087

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Salomon & Ludwin's EXAS Position: Q1 2026 in Review

Salomon & Ludwin sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 9 shares — an estimated $914 sold.

Salomon & Ludwin first reported a position in EXAS in Q3 2025 and held it in 2 quarters. The position peaked at $914 in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Salomon & Ludwin reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Salomon & Ludwin sold 9 Exact Sciences shares in Q1 2026, an estimated $914.
  • Salomon & Ludwin first reported a position in Exact Sciences in Q3 2025 and held it in 2 quarters.
  • Salomon & Ludwin's Exact Sciences position peaked at $914 in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Salomon & Ludwin's 13F filing for Q1 2026, filed 11 May 2026.